Related Experiment Videos
[Surgery for cancer with mediastinal lymph node invasiveness (N2)]
Revue De Pneumologie Clinique
|January 1, 1992
Summary
Surgical resection offers a chance of cure for approximately 20% of patients with N2 disease. Complete resection, potentially combined with chemotherapy, is crucial for improving survival rates in these cases.
Area of Science:
- Oncology
- Thoracic Surgery
- Medical Research
Context:
- N2 disease, a form of advanced cancer, presents unique challenges in treatment planning.
- Surgical intervention is considered for a subset of patients with N2 disease.
Purpose:
- To evaluate the role and outcomes of surgical resection in N2 cases.
- To identify factors influencing survival rates in patients undergoing resection for N2 disease.
Summary:
- Complete surgical resection is indicated in about 20% of N2 cases, offering a potential for cure.
- Achieving complete resection is associated with a potential 5-year survival rate.
- Optimizing outcomes involves strict patient selection and effective chemotherapy, either before or after surgery.
Impact:
- Highlights the curative potential of surgical resection in select N2 patients.
- Emphasizes the importance of multimodal treatment strategies, including chemotherapy, to improve outcomes.
- Provides evidence for considering resection in N2 cases, either upfront or following adjuvant therapy.